Need professional-grade analysis? Visit stockanalysis.com
$8.15B
N/A
704
N/A
Jiangsu Aidea Pharmaceutical Co Ltd (688488) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY19.36, down 2.71% from the previous close.
Over the past year, 688488 has traded between a low of CNY10.11 and a high of CNY22.16. The stock has gained 66.9% over this period. It is currently 12.6% below its 52-week high.
Jiangsu Aidea Pharmaceutical Co Ltd has a market capitalization of $8.15B.
Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July 2025. The company was founded in 2009 and is headquartered in Yangzhou, China.
Side-by-side comparison against top Healthcare peers.